1 Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA Database. Nucleic Acids Res 2020; 48: D948–55.
2 Alter I, Gragert L, Fingerson S, Maiers M, Louzoun Y. HLA class I haplotype diversity is consistent with selection for frequent existing haplotypes. PLoS Comput Biol 2017; 13: e1005693.
3 Lin GG, Scott JG. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2012; 100: 130–4.
4 Loffredo JT, Sidney J, Bean AT, et al. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J Immunol 2009; 182: 7763–75.
5 Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. Clin Microbiol Rev 2009; 22: 370–85.
6 Sanchez-Mazas A. A review of HLA allele and SNP associations with highly prevalent infectious diseases in human populations. Swiss Med Wkly 2020; 150: w20214.
7 Crux NB, Elahi S. Human Leukocyte Antigen (HLA) and immune regulation: How do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections? Front Immunol 2017; 8: 1–26.
8 Parham P. The immune system, 4th edn. Garland Science, 2014.
9 Tamori A, Kawada N. HLA class II associated with outcomes of hepatitis B and C infections. World J Gastroenterol 2013; 19: 5395–401.
10 Ranasinghe S, Cutler S, Davis I, et al. Association of HLA-DRB1-restricted CD4+ T cell responses with HIV immune control. Nat Med 2013; 19: 930–3.
11 Sierra B, Alegre R, Pérez AB, et al. HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol 2007; 68: 531–40.
12 Penn DJ, Damjanovich K, Potts WK. MHC heterozygosity confers a selective advantage against multiple-strain infections. Proc Natl Acad Sci U S A 2002; 99: 11260–4.
13 Takeshima S, Matsumoto Y, Chen J, Yoshida T, Mukoyama H, Aida Y. Evidence for cattle major histocompatibility complex (BoLA) class II DQA1 gene heterozygote advantage against clinical mastitis caused by Streptococci and Escherichia species. Tissue Antigens 2008; 72: 525–31.
14 Evans ML, Neff BD. Major histocompatibility complex heterozygote advantage and widespread bacterial infections in populations of Chinook salmon (Oncorhynchus tshawytscha). Mol Ecol 2009; 18: 4716–29.
15 Niskanen AK, Kennedy LJ, Ruokonen M, et al. Balancing selection and heterozygote advantage in major histocompatibility complex loci of the bottlenecked Finnish wolf population. Mol Ecol 2014; 23: 875–89.
16 Arora J, Pierini F, McLaren PJ, Carrington M, Fellay J, Lenz TL. HLA Heterozygote Advantage against HIV-1 Is Driven by Quantitative and Qualitative Differences in HLA Allele-Specific Peptide Presentation. Mol Biol Evol 2020; 37: 639–50.
17 Hraber P, Kuiken C, Yusim K. Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection. Hepatology 2007; 46: 1713–21.
18 Spurgin LG, Richardson DS. How pathogens drive genetic diversity: MHC, mechanisms and misunderstandings. Proceedings Biol Sci 2010; 277: 979–88.
19 Sommer S. The importance of immune gene variability (MHC) in evolutionary ecology and conservation. Front Zool 2005; 2: 16.
20 Lobkovsky AE, Levi L, Wolf YI, et al. Multiplicative fitness, rapid haplotype discovery, and fitness decay explain evolution of human MHC. Proc Natl Acad Sci U S A 2019; 116: 14098–104.
21 Oh HLJ, Gan SKE, Bertoletti A, Tan YJ. Understanding the T cell immune response in SARS coronavirus infection. Emerg Microbes Infect 2012; 1: 0.
22 Sanchez-Mazas A. HLA studies in the context of coronavirus outbreaks. Swiss Med Wkly 2020; 150: w20248.
23 Keicho N, Itoyama S, Kashiwase K, et al. Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population. Hum Immunol 2009; 70: 527–31.
24 Lin M, Tseng HK, Trejaut JA, et al. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet 2003; 4: 1–7.
25 Chen YMA, Liang SY, Shih YP, et al. Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003. J Clin Microbiol 2006; 44: 359–65.
26 Xiong P, Zeng X, Song MS, et al. Lack of association between HLA-A, -B and -DRB1 alleles and the development of SARS: A cohort of 95 SARS-recovered individuals in a population of Guangdong, southern China. Int J Immunogenet 2008; 35: 69–74.
27 Hajeer AH, Balkhy H, Johani S, Yousef MZ, Arabi Y. Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection. Ann Thorac Med 2016; 11: 211–3.
28 Pisanti S, Deelen J, Gallina AM, et al. Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19. J Transl Med 2020; 18: 1–16.
29 Wang F, Huang S, Gao R, et al. Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility. Cell Discov 2020; 6. DOI:10.1038/s41421-020-00231-4.
30 Tomita Y, Ikeda T, Sato R, Sakagami T. Association between HLA gene polymorphisms and mortality of COVID-19: An in silico analysis. Immunity, Inflamm Dis 2020. DOI:10.1002/iid3.358.
31 Arunachalam PS, Wimmers F, Mok CKP, et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science (80- ) 2020; 369: 1210–20.
32 Ellinghaus D, Degenhardt F, Bujanda L, et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med 2020. DOI:10.1056/NEJMoa2020283.
33 Pairo-Castineira E, Clohisey S, Klaric L, et al. Genetic mechanisms of critical illness in Covid-19. Nature 2020; published online Dec. DOI:10.1038/s41586-020-03065-y.
34 Roberts GHL, Park DS, Coignet M V, et al. AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci. medRxiv 2020; : 2020.10.06.20205864.
35 Shelton JF, Shastri AJ, Ye C, et al. Trans-ethnic analysis reveals genetic and non-genetic associations with COVID-19 susceptibility and severity. medRxiv 2020; : 2020.09.04.20188318.
36 Oksenberg JR, Barcellos LF, Cree BAC, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004; 74: 160–7.
37 Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001; 68: 686–99.
38 Klitz W, Gragert L, Maiers M, et al. Genetic differentiation of Jewish populations. Tissue Antigens 2010; 76: 442–58.
39 Khankhanian P, Matsushita T, Madireddy L, et al. Genetic contribution to multiple sclerosis risk among Ashkenazi Jews. BMC Med Genet 2015; 16: 1–10.
40 Liu X, Cheng R, Verbitsky M, et al. Genome-Wide association study identifies candidate genes for Parkinson’s disease in an Ashkenazi Jewish population. BMC Med Genet 2011; 12: 104.
41 Goes FS, McGrath J, Avramopoulos D, et al. Genome-wide association study of schizophrenia in Ashkenazi Jews. Am J Med Genet Part B, Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 2015; 168: 649–59.
42 Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 31: 2165–8.
43 Manor S, Halagan M, Shriki N, et al. High-resolution HLA A∼B∼DRB1 haplotype frequencies from the Ezer Mizion Bone Marrow Donor Registry in Israel. Hum Immunol 2016; 77. DOI:10.1016/j.humimm.2016.09.004.
44 Maiers M, Halagan M, Gragert L, et al. GRIMM: GRaph IMputation and matching for HLA genotypes. Bioinformatics 2019; 35: 3520–3.
45 Yoav Benjamini, Yosef Hochberg. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B 1995; 57: 289–300.
46 Polosa R, Caci G. COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine. Intern Emerg Med 2020; 15: 853–6.
47 Abate BB, Kassie AM, Kassaw MW, Aragie TG, Masresha SA. Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis. BMJ Open 2020; 10: e040129.
48 Nasir J WB and VK. COVID-19 HGI Results for Data Freeze 4. https://www.covid19hg.org/blog/2020-11-24-covid-19-hgi-results-for-data-freeze-4-october-2020/. 2020. https://www.covid19hg.org/blog/2020-11-24-covid-19-hgi-results-for-data-freeze-4-october-2020/.
49 Zeberg H, Pääbo S. The major genetic risk factor for severe COVID-19 is inherited from Neandertals. bioRxiv 2020; : 2020.07.03.186296.
50 Tam V, Patel N, Turcotte M, Bossé Y, Paré G, Meyre D. Benefits and limitations of genome-wide association studies. Nat Rev Genet 2019; 20: 467–84.
51 Maiers M, Halagan M, Gragert L, et al. GRIMM: GRaph IMputation and matching for HLA genotypes. Bioinformatics 2019; 35: 3520–3.